Skip to content
Riskpilot
← Back to search
Sign in
Get full access
SibbarPharma AB
AB
Active
Org 5590038906
Skånegatan 20, 216 11
Limhamn
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2015
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
SibbarPharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
1M
2022
1M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
1M
2022
1M
2023
1M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
612
552
774
1 023
1 414
Staff expenses
—
—
—
—
—
EBITDA
428
270
564
721
1 114
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
428
270
564
721
1 114
Net financials
169
1
12
26
13
Profit before tax
445
302
534
661
915
Tax
−98
−65
−113
−143
−197
Net profit
347
237
421
518
718
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
2 018
2 404
2 924
3 069
3 915
Equity
1 050
1 287
1 528
1 455
1 757
Long-term debt
0
0
0
0
0
Short-term debt
171
353
590
722
1 055
Total debt
171
353
590
722
1 055
Financial ratios
5-year trend
EBITDA margin
78.8%
This company
15.8%
Market median
+399% vs market
2020
2024
Equity ratio
44.9%
This company
38.2%
Market median
+18% vs market
2020
2024
Return on equity
40.9%
This company
18.4%
Market median
+122% vs market
2020
2024
Net profit margin
50.8%
This company
8.1%
Market median
+527% vs market
2020
2024
Asset turnover
0.36×
This company
1.12×
Market median
-68% vs market
2020
2024
Debt / equity
1.23×
This company
0.62×
Market median
-98% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on SibbarPharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
